0001209191-19-041793.txt : 20190711 0001209191-19-041793.hdr.sgml : 20190711 20190711131701 ACCESSION NUMBER: 0001209191-19-041793 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190709 FILED AS OF DATE: 20190711 DATE AS OF CHANGE: 20190711 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Torti Frank CENTRAL INDEX KEY: 0001647805 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38667 FILM NUMBER: 19950810 MAIL ADDRESS: STREET 1: 2855 SAND HILL ROAD CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Urovant Sciences Ltd. CENTRAL INDEX KEY: 0001740547 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: D0 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 5281 CALIFORNIA AVENUE STREET 2: SUITE 100 CITY: IRVINE STATE: CA ZIP: 92617 BUSINESS PHONE: 949-226-6029 MAIL ADDRESS: STREET 1: 5281 CALIFORNIA AVENUE STREET 2: SUITE 100 CITY: IRVINE STATE: CA ZIP: 92617 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-07-09 0 0001740547 Urovant Sciences Ltd. UROV 0001647805 Torti Frank C/O UROVANT SCIENCES, INC. 5281 CALIFORNIA AVENUE, SUITE 100 IRVINE CA 92617 1 0 0 0 Stock Option (Right to Buy) 8.78 2019-07-09 4 A 0 25000 0.00 A 2029-07-09 Common Shares 25000 25000 D The shares underlying the option shall vest and become exercisable on July 9, 2020, subject to the Reporting Person providing continuous service to the Issuer through such vesting date. /s/ Bryan Smith, Attorney-in-Fact 2019-07-11